BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29389716)

  • 21. Risk-to-Benefit Relationship of Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies with Immediate Reconstruction.
    Alba B; Schultz BD; Cohen D; Qin AL; Chan W; Tanna N
    Plast Reconstr Surg; 2019 Jul; 144(1):1-9. PubMed ID: 31246789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
    Hooper RC; Hsu J; Duncan A; Bensenhaver JM; Newman LA; Kidwell KM; Chung KC; Momoh AO
    Plast Reconstr Surg; 2019 May; 143(5):936e-945e. PubMed ID: 31033815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contralateral Prophylactic Mastectomy in the Era of Financial Toxicity: An Additional Point for Concern?
    Offodile AC; Hwang ES; Greenup RA
    Ann Surg; 2020 May; 271(5):817-818. PubMed ID: 31592896
    [No Abstract]   [Full Text] [Related]  

  • 24. Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg; 2022 Mar; 223(3):538. PubMed ID: 35177234
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
    Tuttle TM; Burke EE; Hui JYC
    Ann Surg Oncol; 2021 Sep; 28(9):4764-4766. PubMed ID: 33796999
    [No Abstract]   [Full Text] [Related]  

  • 26. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
    Yang Y; Pan L; Shao Z
    Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications in patients with unilateral breast cancer who undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Surgery; 2018 Dec; 164(6):1347-1350. PubMed ID: 30033183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost.
    Boughey JC; Schilz SR; Van Houten HK; Zhu L; Habermann EB; Lemaine V
    Ann Surg Oncol; 2017 Oct; 24(10):2957-2964. PubMed ID: 28766231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discussion: Complications Associated with Contralateral Prophylactic Mastectomy: A Systematic Review and Meta-Analysis.
    Luce EA
    Plast Reconstr Surg; 2022 Oct; 150():73S-74S. PubMed ID: 36170450
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
    Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contralateral prophylactic mastectomy at the time of delayed microvascular breast reconstruction adversely affects patient-reported outcomes: A retrospective cohort study.
    Kerrebijn I; Retrouvey H; Härmä M; Sebastiampillai S; Zhong T; Hofer SOP; O'Neill AC
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):785-791. PubMed ID: 33214123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of breast reconstruction following prophylactic bilateral mastectomy.
    Lim DW; Narod SA
    Breast J; 2020 Sep; 26(9):1637-1638. PubMed ID: 32783312
    [No Abstract]   [Full Text] [Related]  

  • 35. Contralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider Recommendations.
    Fayanju OM; Hwang ES
    JAMA Surg; 2017 Mar; 152(3):282-283. PubMed ID: 28002558
    [No Abstract]   [Full Text] [Related]  

  • 36. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
    J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply: Complications in unilateral breast cancer patients who undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar AB
    Surgery; 2019 Feb; 165(2):486-496. PubMed ID: 30385125
    [No Abstract]   [Full Text] [Related]  

  • 39. Occult disease in reduction mammoplasties and prophylactic mastectomies.
    Nomikos A; Husain EA; Graham AD
    Breast J; 2020 Apr; 26(4):691-696. PubMed ID: 31448509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.
    Findlay-Shirras L; Lima I; Smith G; Clemons M; Arnaout A
    Breast Cancer Res Treat; 2021 Jan; 185(2):517-525. PubMed ID: 33128192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.